FDA Inspection 1311002 - Granules Pharmaceuticals Inc. - April 03, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Granules Pharmaceuticals Inc.

Record Details

This FDA Inspection record concerns Granules Pharmaceuticals Inc., with an inspection on April 3, 2026, issued by the Baltimore District Office, covering human drugs.

Company: Granules Pharmaceuticals Inc.
Inspection Date: April 3, 2026
Product Type: Human Drugs
Office: Baltimore District Office

Open in Dashboard

ID · 920e888f-8fba-4596-ac5e-b8a55ca5eb4f

Violation Codes4

21 CFR 211.166(a)21 CFR 211.18821 CFR 211.19221 CFR 211.58

Full citation text and observation details available on the Dashboard.